SI1499888T1 - Konformacijsko omejeni peptidi ki vežejo ORL receptor - Google Patents

Konformacijsko omejeni peptidi ki vežejo ORL receptor

Info

Publication number
SI1499888T1
SI1499888T1 SI200331876T SI200331876T SI1499888T1 SI 1499888 T1 SI1499888 T1 SI 1499888T1 SI 200331876 T SI200331876 T SI 200331876T SI 200331876 T SI200331876 T SI 200331876T SI 1499888 T1 SI1499888 T1 SI 1499888T1
Authority
SI
Slovenia
Prior art keywords
orl
receptor
present
conformationally constrained
bind
Prior art date
Application number
SI200331876T
Other languages
English (en)
Inventor
Donald J Kyle
Original Assignee
Euro Celtique Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa
Publication of SI1499888T1 publication Critical patent/SI1499888T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SI200331876T 2002-04-29 2003-04-29 Konformacijsko omejeni peptidi ki vežejo ORL receptor SI1499888T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US37674502P 2002-04-29 2002-04-29
EP03736501A EP1499888B1 (en) 2002-04-29 2003-04-29 Conformationally constrained peptides that bind the orl-1 receptor
PCT/US2003/013097 WO2003093294A2 (en) 2002-04-29 2003-04-29 Conformationally constrained peptides that bind the orl-1 receptor

Publications (1)

Publication Number Publication Date
SI1499888T1 true SI1499888T1 (sl) 2010-11-30

Family

ID=29401398

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200331876T SI1499888T1 (sl) 2002-04-29 2003-04-29 Konformacijsko omejeni peptidi ki vežejo ORL receptor

Country Status (12)

Country Link
US (1) US20040259775A1 (sl)
EP (1) EP1499888B1 (sl)
AT (1) ATE473439T1 (sl)
AU (1) AU2003237119A1 (sl)
CY (1) CY1111243T1 (sl)
DE (1) DE60333270D1 (sl)
DK (1) DK1499888T3 (sl)
ES (1) ES2348604T3 (sl)
HK (1) HK1122098A1 (sl)
PT (1) PT1499888E (sl)
SI (1) SI1499888T1 (sl)
WO (1) WO2003093294A2 (sl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050266575A1 (en) * 2004-05-27 2005-12-01 Mayo Kevin H Pharmacophores for nociceptin, methods of obtaining and using in screening for nociceptin mimics
ITFE20050003A1 (it) 2005-02-15 2006-08-16 Ufpeptides S R L Agonisti pieni e parziali ed antagonisti del recettore per nocicettina/orfanina fq ad elevata potenza.
WO2010091122A1 (en) 2009-02-03 2010-08-12 Amunix, Inc. Extended recombinant polypeptides and compositions comprising same
US8703717B2 (en) 2009-02-03 2014-04-22 Amunix Operating Inc. Growth hormone polypeptides and methods of making and using same
US8680050B2 (en) * 2009-02-03 2014-03-25 Amunix Operating Inc. Growth hormone polypeptides fused to extended recombinant polypeptides and methods of making and using same
EA030619B1 (ru) * 2009-06-08 2018-09-28 Амуникс Оперейтинг Инк. Гибридный белок, включающий последовательности гормона роста и xten, способ его получения и применения
US9849188B2 (en) 2009-06-08 2017-12-26 Amunix Operating Inc. Growth hormone polypeptides and methods of making and using same
KR20120100887A (ko) 2009-07-27 2012-09-12 트라이제미나 인코퍼레이티드 통증 치료 방법
FR2948809B1 (fr) * 2009-07-31 2012-08-17 St Microelectronics Rousset Amplificateur de lecture faible puissance auto-minute
WO2011123830A2 (en) 2010-04-02 2011-10-06 Amunix Operating Inc. Alpha 1-antitrypsin compositions and methods of making and using same
EP2552967A4 (en) * 2010-04-02 2014-10-08 Amunix Operating Inc BINDING FUSION PROTEINS, BINDING FUSION PROTEIN MEDICINAL CONJUGATES, XTEN MEDICAMENT CONJUGATES, AND METHOD FOR THEIR PREPARATION AND USE
WO2014102590A1 (en) 2012-12-27 2014-07-03 Purdue Pharma L.P. Substituted piperidin-4-amino-type compounds and uses thereof
WO2014102589A1 (en) 2012-12-27 2014-07-03 Purdue Pharma L.P. Quinazolin-4(3h)-one-type piperidine compounds and uses thereof
US9963458B2 (en) 2012-12-27 2018-05-08 Purdue Pharma L.P. Indole and indoline-type piperidine compounds and uses thereof
FI3242676T3 (fi) 2015-01-07 2023-11-07 TONIX Pharmaceuticals Holding Corp Magnesiumipitoisia oksitosiiniformulaatioita ja käyttömenetelmiä

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4698327A (en) * 1985-04-25 1987-10-06 Eli Lilly And Company Novel glycopeptide derivatives
US5098995A (en) * 1987-05-22 1992-03-24 The Salk Institute For Biological Studies GRF Analogs VIIA
US5639726A (en) * 1994-09-30 1997-06-17 The Regents Of The University Of Michigan Peptide mediated enhancement of thrombolysis methods and compositions
US5821219A (en) * 1995-08-11 1998-10-13 Oregon Health Sciences University Opioid antagonists and methods of their use
AU8334298A (en) * 1997-07-15 1999-02-10 Novo Nordisk A/S Nociceptin analogues
US6777388B1 (en) * 1998-08-21 2004-08-17 Clf Medical Technology Acceleration Program, Inc. Leptin-related peptides
US6586403B1 (en) * 2000-07-20 2003-07-01 Salpep Biotechnology, Inc. Treating allergic reactions and inflammatory responses with tri-and dipeptides
WO2003088914A2 (en) * 2002-04-18 2003-10-30 The University Of Iowa Research Foundation Methods of inhibiting and treating bacterial biofilms by metal chelators

Also Published As

Publication number Publication date
EP1499888B1 (en) 2010-07-07
US20040259775A1 (en) 2004-12-23
EP1499888A4 (en) 2005-10-19
AU2003237119A8 (en) 2003-11-17
ATE473439T1 (de) 2010-07-15
ES2348604T3 (es) 2010-12-09
HK1122098A1 (en) 2009-05-08
DE60333270D1 (de) 2010-08-19
AU2003237119A1 (en) 2003-11-17
DK1499888T3 (da) 2010-10-25
WO2003093294A3 (en) 2004-09-23
PT1499888E (pt) 2010-10-14
EP1499888A2 (en) 2005-01-26
CY1111243T1 (el) 2015-06-11
WO2003093294A2 (en) 2003-11-13

Similar Documents

Publication Publication Date Title
HK1122098A1 (en) Conformationally constrained peptides that bind the orl-1 receptor
DE69823520D1 (de) Noribogain zur behandlung von schmerzen und drogenabhängigkeit
EE200200510A (et) POL1212 aminohappejärjestust kodeeriv DNA, seda sisaldav ekspressioonivektor, sea modifitseeritud VIII- tegur, sellel põhinev ravimkompositsioon ningmeetod sea modifitseeritud VIII-teguri aminohappejärjestust omava valgu valmistamiseks
HK1069316A1 (en) Hmgb1 protein inhibitors and/or antagonists for the treatment of vascular diseases
DE60234183D1 (de) Verwendung von methylnaltrexon zur behandlung von immunsuppression
ATE361318T1 (de) Polypeptiden, die die april-vermittelte aktivierung von t-und b-zellen hemmen
AU2003216321A1 (en) Tamper-resistant transdermal opioid delivery devices
IS4261A (is) Nýir peptíð-ópíóíðar til meðhöndlunar á verkjum og notkun þeirra
RU2008121750A (ru) Ионофоретическая доставка ротиготина для лечения болезни паркинсона
DE69736634D1 (de) Antagonisten des intestinotrophen glp-2 peptides
EA200401106A1 (ru) Химерные гибридные анальгетики
DE602004006869D1 (de) 5ht2c rezeptor agonisten zur behandlung von diabetes und fettleibigkeit
HUP0101546A2 (hu) Opioid antagonistát és NMDA-receptor komplex modulátort tartalmazó gyógyászati készítmény alkohol- és drogfüggőség kezelésére
HUP0401485A2 (hu) Kiválasztott opioidok és muszkarin-antagonisták kombinációját tartalmazó gyógyszerkészítmény vizeletinkontinencia kezelésére
CN101454338A (zh) κ阿片样受体肽的N-氧化物
CY1110152T1 (el) Χρηση συνδυασμου μορφινης και τουλαχιστον ενος ανταγωνιστη φυσικου οπιοειδους στην αγωγη της εξαρτησης απο φυσικα οπιοειδη και στην προληψη της μη στοματικης καταχρησης φυσικων οπιοειδων σε εξαρτημενους απο φυσικα οπιοειδη
HUP0401915A2 (hu) 4-[4-Piperidinilidén-(3-karbamoil-fenil)-metil]-benzamid-származékok és alkalmazásuk fájdalom, gerincsérülések vagy gasztrointesztinális rendellenességek kezelésére és ezeket tartalmazó gyógyszerkészítmények
HUP0401022A2 (hu) Eljárás alkoholizmus vagy alkoholfüggőség kezelésére szolgáló, opioid-antagonistát tartalmazó gyógyszerkészítmények előállítására
Hiramatsu et al. Long‐lasting antinociceptive effects of a novel dynorphin analogue, Tyr‐D‐Ala‐Phe‐Leu‐Arg ψ (CH2NH) Arg‐NH2, in mice
WO2007144979A1 (ja) ペプチド誘導体
KR100488038B1 (ko) 기관 보호 활성을 지닌 신규한 신체 보호 화합물 펩티드염, 이의 제조 방법 및 치료에서의 이의 용도
GB0120022D0 (en) Conjugate
DE60330857D1 (de) 5-ht4 antagonisten zur behandlung von herzversagen
BR0005318A (pt) Utilização de inibidores de secreção da apo b/mtp e agentes antiobesidade
WO2003106666A3 (en) VARIANTS OF PROTEIN C WITH MODIFIED PROPERTIES